Skip to content

Dexmedetomine vs Dexamethasone in TAB Block for Abdominal Surgries

A Comparative Study Between the Use of Dexmedetomidine Versus Dexamethasone as Adjuvant to Bupivacaine in Ultrasound-guided Transversus Abdominis Plane Block for Post-operative Pain Relief in Patients Undergoing Lower Open Abdominal Surgeries

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05323565
Enrollment
45
Registered
2022-04-12
Start date
2022-04-01
Completion date
2022-07-05
Last updated
2022-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

Randomized controlled clinical Trial to compare the efficacy and duration of postoperative analgesia achieved after adding dexmedetomidine or dexamethasone to bupivacaine in TAP block for lower open abdominal surgeries.

Detailed description

A Comparative study between the use of dexmedetomidine versus dexamethasone as adjuvant to bupivacaine in ultrasound-guided transversus abdominis plane block for post-operative pain relief in patients undergoing lower open abdominal surgeries

Interventions

DRUGDexmedetomidine

adjuvants to 0.25 bupivacaine in TAB block.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Adult patients, Age 20-60 years. Elective operation under general anesthesia. Physical Status: ASA I and II Patients. Body mass index 25-35 kg/m2.

Exclusion criteria

* Infection at site of injection. * Patient refusal. * Psychiatric or physical illness that lead to inability to cooperate, speak or read. * Abdominal operations under spinal anesthesia. * History or evidence of coagulopathy. * Known allergies to drugs used . * Preexisting neurological disorders.

Design outcomes

Primary

MeasureTime frameDescription
1st time for rescue analgesiafirst 24 hours post-operativelyTime to first analgesia requirment(starting from drug injection)

Secondary

MeasureTime frameDescription
Pain score- Visual Analogue Score (VAS)First 24 hours post-operatively.It ranges from 0 indicating no pain till 10 indicating severe intolerable pain with variable degrees of ascending pain in between\] was assessed at 0 min (AT PACU), 2hr,6 hr, 12 hr, 18 hr, and 24 hr postoperatively.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026